Keyphrases
Breast Cancer
100%
Treatment Response
100%
Prognostic Biomarker
100%
Pathological Complete Response
100%
Biomarker Model
100%
Non-responders
75%
Chemotherapy
75%
Breast Cancer Patients
50%
Mathematical Functions
50%
Clinical Stage I
50%
Clinical Centers
25%
Oncogenesis
25%
Immune Response
25%
Cell Proliferation
25%
Human Epidermal Growth Factor Receptor 2 (HER2)
25%
Significant Genes
25%
Cancer Recurrence
25%
Paclitaxel
25%
Drug Resistance
25%
Cell Invasion
25%
Cell Migration
25%
Incidence Rate
25%
Patients with Breast Cancer
25%
Transcription Regulation
25%
Model Complex
25%
Annual Incidence
25%
Tumor Tissue
25%
Lethal Cancer
25%
Female Population
25%
Overall Sensitivity
25%
Hormone Receptor
25%
Global Gene Expression Analysis
25%
Fluorouracil
25%
Doxorubicin-cyclophosphamide
25%
Patient's Will
25%
Biochemistry, Genetics and Molecular Biology
Cell Migration
100%
Gene Expression Profiling
100%
Transcription
100%
Doxorubicin
100%
Immune Response
100%
Cell Proliferation
100%
Cell Invasion
100%
Cyclophosphamide
100%
Carcinogenesis
100%
Hormone Receptor
100%
Drug Resistance
100%
Fluorouracil
100%
Pharmacology, Toxicology and Pharmaceutical Science
Breast Cancer
100%
Biological Marker
83%
Chemotherapy
50%
Malignant Neoplasm
33%
Doxorubicin
16%
Paclitaxel
16%
Cyclophosphamide
16%
Cancer Recurrence
16%
Neoplasm
16%
Carcinogenesis
16%
Drug Resistance
16%
Fluorouracil
16%
Hormone Receptor
16%
Immunology and Microbiology
Prognostic Biomarker
100%
Drug Resistance
25%
Immune Response
25%
Cell Proliferation
25%
Cell Invasion
25%
Gene Expression Profiling
25%
Cell Migration
25%
Cyclophosphamide
25%